Texas won a $41.5M settlement after accusing Pfizer and Tris Pharma of knowingly distributing defective ADHD medication, Quillivant XR, from 2012–2018. The lawsuit claims the companies manipulated drug tests to hide manufacturing failures, leading Medicaid children to receive an ineffective product. The case began with a whistleblower and marks a major action by Texas against pharmaceutical misconduct.
A breach of trust: Texas exposes defective ADHD drug in landmark settlement
